• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扫清医用大麻周围的迷雾。

Clearing the smoke around medical marijuana.

机构信息

Department of Family Medicine and Department of Anesthesia, McGill University, Montreal, Quebec, Canada.

出版信息

Clin Pharmacol Ther. 2011 Dec;90(6):769-71. doi: 10.1038/clpt.2011.241.

DOI:10.1038/clpt.2011.241
PMID:22089341
Abstract

The hazy world of "medical marijuana" continues to cry out for clear data on which to base medical decision making and rational policy design. In this issue of Clinical Pharmacology & Therapeutics, Abrams and colleagues report that vaporized cannabis does not meaningfully affect opioid plasma levels and may even augment the efficacy of oxycodone and morphine in patients with chronic non-cancer pain. This Commentary considers the implications of this work for clinical practice and further research initiatives.

摘要

在“医用大麻”这个模糊不清的领域,仍然迫切需要清晰的数据来为医疗决策和合理的政策设计提供依据。在本期《临床药理学与治疗学》杂志上,Abrams 及其同事报告称,汽化大麻不会显著影响阿片类药物的血浆水平,甚至可能增强慢性非癌痛患者使用羟考酮和吗啡的疗效。本文述评探讨了这项工作对临床实践和进一步研究计划的意义。

相似文献

1
Clearing the smoke around medical marijuana.扫清医用大麻周围的迷雾。
Clin Pharmacol Ther. 2011 Dec;90(6):769-71. doi: 10.1038/clpt.2011.241.
2
The role of cannabinoids in chronic pain patients remains hazy.大麻素在慢性疼痛患者中的作用仍不明确。
Clin Pharmacol Ther. 2012 Jun;91(6):972; author reply 972-3. doi: 10.1038/clpt.2012.27.
3
Cannabinoid-opioid interaction in chronic pain.慢性疼痛中的大麻素-阿片类相互作用。
Clin Pharmacol Ther. 2011 Dec;90(6):844-51. doi: 10.1038/clpt.2011.188. Epub 2011 Nov 2.
4
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.在英国,对于一线治疗药物吗啡治疗失败的严重非恶性慢性疼痛患者,与羟考酮控释片相比,曲马多缓释片的成本效益。
J Med Econ. 2012;15(4):724-36. doi: 10.3111/13696998.2012.670174. Epub 2012 Mar 28.
5
Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.吗啡还是羟考酮用于癌症相关疼痛?一项随机、开放标签、对照试验。
J Pain Symptom Manage. 2015 Feb;49(2):161-72. doi: 10.1016/j.jpainsymman.2014.05.021. Epub 2014 Jun 26.
6
Only modest long-term opioid dose escalation occurs over time in chronic nonmalignant pain management.在慢性非恶性疼痛管理中,随着时间推移,阿片类药物的长期剂量仅出现适度增加。
J Pain Palliat Care Pharmacother. 2013 Dec;27(4):370-7. doi: 10.3109/15360288.2013.846957. Epub 2013 Oct 21.
7
Opioid formulations: tailoring to the needs in chronic pain.
Eur J Pain. 2001;5 Suppl A:109-11. doi: 10.1053/eujp.2001.0291.
8
The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain.在一项针对疼痛的随机、对照交叉临床试验中研究了口服屈大麻酚的主观精神活性作用。
Clin J Pain. 2014 Jun;30(6):472-8. doi: 10.1097/AJP.0000000000000022.
9
Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain.口服吗啡与羟考酮两种协同比例组合与吗啡相比治疗慢性非癌性疼痛患者的耐受性和疗效
J Opioid Manag. 2012 Mar-Apr;8(2):89-98.
10
[Difference in tolerance to anti-hyperalgesic effect and its molecular mechanisms between chronic treatment with morphine, fentanyl and oxycodone in a chronic pain-like state].[慢性疼痛样状态下吗啡、芬太尼和羟考酮长期治疗的抗痛觉过敏作用耐受性差异及其分子机制]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Nov;28(5-6):169-76.

引用本文的文献

1
Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada.大麻的治疗用途:加拿大安大略省成年人中的流行情况及特征
Can J Public Health. 2017 Sep 14;108(3):e282-e287. doi: 10.17269/CJPH.108.6130.
2
Integrating cannabis into clinical cancer care.将大麻纳入临床癌症护理。
Curr Oncol. 2016 Mar;23(2):S8-S14. doi: 10.3747/co.23.3099. Epub 2016 Mar 16.
3
The current status of medical marijuana in the United States.美国医用大麻的现状。
Hawaii J Med Public Health. 2014 Apr;73(4):105-8.